NCT00332605View on ClinicalTrials.gov

N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
Methamphetamine Dependence
Interventions
DRUG

Naltrexone plus N-Acetyl Cysteine

daily

DRUG

Placebo

daily

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT00332605 - N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence | Biotech Hunter | Biotech Hunter